Search hospitals > Illinois > Chicago
Northwestern University Feinberg School of Medicine
Claim this profileChicago, Illinois 60611
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for AIDS
Conducts research for Cancer
Conducts research for Breast Cancer
491 reported clinical trials
41 medical researchers
Summary
Northwestern University Feinberg School of Medicine is a medical facility located in Chicago, Illinois. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, AIDS, Cancer, Breast Cancer and other specialties. Northwestern University Feinberg School of Medicine is involved with conducting 491 clinical trials across 571 conditions. There are 41 research doctors associated with this hospital, such as Sunandana Chandra, Amy Paller, Thomas Schnitzer, and Devalingam Mahalingam, MBBChBAO.Top PIs
Sunandana ChandraNorthwestern University3 years of reported clinical research
Expert in Melanoma
Expert in Skin Cancer
22 reported clinical trials
31 drugs studied
Amy PallerNorthwestern University7 years of reported clinical research
Studies Atopic Dermatitis
Studies Epidermolysis Bullosa
20 reported clinical trials
18 drugs studied
Thomas SchnitzerNorthwestern University2 years of reported clinical research
Studies Osteoarthritis
Studies Osteoarthritis Treatment Costs
18 reported clinical trials
24 drugs studied
Devalingam Mahalingam, MBBChBAONorthwestern University6 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
18 reported clinical trials
54 drugs studied
Clinical Trials running at Northwestern University Feinberg School of Medicine
Intermittent Claudication
Peripheral Vascular Disease
Breast Cancer
Peripheral Arterial Disease
Limited Mobility
Peripheral Artery Disease
Lung Cancer
Atopic Dermatitis
Obesity
Cancer
Exercise and Beetroot Juice
for Peripheral Arterial Disease
Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ischemia. However, supervised exercise is inaccessible or burdensome for most PAD patients. Investigators hypothesize that home-based exercise combined with lower extremity revascularization will significantly improve walking performance compared to revascularization alone in patients with PAD undergoing revascularization for disabling PAD. Investigators further hypothesize that inorganic nitrate, a major source of nitric oxide (NO) abundant in beetroot juice, will improve walking performance after lower extremity revascularization, compared to placebo. In preclinical models, NO inhibits inflammation, neointimal hyperplasia, thrombosis, and vascular smooth muscle cell migration at sites of revascularization. NO increases angiogenesis and perfusion, repairs skeletal muscle damaged by ischemia, and stimulates mitochondrial activity. In a randomized clinical trial with a 2 x 2 factorial design, the trial will test the following two primary hypotheses in 386 patients randomized within three months of a successful lower extremity revascularization for disabling PAD: First, that home-based exercise combined with lower extremity revascularization will improve six-minute walk distance more than revascularization alone at 6-month follow-up (Primary Aim #1). Second, that nitrate-rich beetroot juice combined with lower extremity revascularization will improve six-minute walk, compared to placebo combined with revascularization at 6-month follow-up (Primary Aim #2).
Recruiting1 award Phase 31 criteria
Fisetin
for PAD
The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal muscle, and both subcutaneous and inter muscular adipose tissue and improve 6-minute walk distance in 34 people with peripheral artery disease (PAD). the investigators will determine whether greater declines in abundance of cells with senescent markers are associated with greater improvement in 6-minute walk distance in people with peripheral artery disease. In exploratory analyses, the investigators will assess whether Fisetin reduces interleukin-6 (IL-6) and novel senescent markers in adipose tissue, muscle, and/or blood.
Recruiting0 awards Phase 22 criteria
Exercise and Beetroot Juice
for Peripheral Artery Disease
RESIST PAD is a randomized trial of 200 PAD patients to establish: 1) whether a 12-week exercise intervention significantly increases Δ nitrite at 12-week follow-up, compared to control; 2) whether exercise "responders" have greater Δ nitrite increases compared to "non-responders"; 3) among non-responders, whether supplementing exercise with nitrate-rich beetroot juice between weeks 13-24 increases Δ nitrite and improves 6-minute walk at 24-week follow-up.
Recruiting0 awards Phase 22 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northwestern University Feinberg School of Medicine?
Northwestern University Feinberg School of Medicine is a medical facility located in Chicago, Illinois. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, AIDS, Cancer, Breast Cancer and other specialties. Northwestern University Feinberg School of Medicine is involved with conducting 491 clinical trials across 571 conditions. There are 41 research doctors associated with this hospital, such as Sunandana Chandra, Amy Paller, Thomas Schnitzer, and Devalingam Mahalingam, MBBChBAO.
Where is Northwestern University Feinberg School of Medicine located?
The Northwestern University Feinberg School of Medicine, situated in downtown Chicago at 420 E. Superior St., is part of the Northwestern Memorial Hospital complex. The Feinberg Pavilion, offering inpatient care services and private patient rooms, is located at 251 E. Huron St. Both locations are easily accessible by public transportation.
Who should I call to ask about financial aid or insurance network?
**Northwestern University's Feinberg School of Medicine Financial Assistance**
- **Hospital Financial Assistance:** Contact the Financial Aid Experts at 312-503-1923 or via email at cgonzalez@northwestern.edu.
- **Insurance Inquiries:** Reach out to Student Health Insurance at 312-503-1242 for the Chicago Campus or 847-491-3621 for the Evanston Campus.
- **Northwestern Medicine's Financial Assistance Program:** Call 800.423.0523 (TTY: 711) or visit [nm.org/financialassistance](http://nm.org/financialassistance) for more information.
What insurance does Northwestern University Feinberg School of Medicine accept?
Northwestern University Feinberg School of Medicine and its affiliated hospitals accept a broad range of insurance plans, including commercial, government, exchange arenas, and Medicare assignment. For US-based faculty and staff, Northwestern offers four Blue Cross Blue Shield medical plans and an ACA Value PPO option, while Qatar-based faculty and staff have access to the Cigna International Health plan. All full-time students must maintain health insurance through the university-contracted Aetna Insurance Company, with the NU-SHIP being mandatory for international students holding a J-1 or F-1 U.S. visa.
What awards or recognition has Northwestern University Feinberg School of Medicine received?
Northwestern University Feinberg School of Medicine, located in Chicago, Illinois, is recognized as a top 20 medical school, receiving $706 million in awards for the 2022-2023 academic year, with $477 million from the National Institutes of Health (NIH). This funding places Feinberg 15th in NIH funding rankings among all American Medical Schools. The school excels in various medical specialties, ranking highly in Physical Medicine and Rehabilitation (1), Public Health (1), Urology (2), Obstetrics and Gynecology (3), Dermatology (4), Anatomy/Cell Biology (7), Neurology (7), Neuroscience (9), Surgery (10), Neurosurgery (11), Internal Medicine (16), Pharmacology (17), and Microbiology, Immunology and Virology (20).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.